Schneider P M, Fellbaum C, Fink U, Bollschweiler E, Präuer H W
Department of Surgery, Technical University of Munich Medical Center, Germany.
Ann Surg Oncol. 1997 Jan;4(1):46-56. doi: 10.1007/BF02316810.
The prognostic importance of various clinical variables (age, sex, association with myasthenia gravis), staging according to Masaoka, histologic type according to the Marino/Kirchner/Müller-Hermelink (MKM-H) classification, and residual tumor category (R category) was evaluated in a retrospective analysis.
Eighty-two patients with epithelial thymic tumors (ETTs) treated in the period 1969-1993 were evaluated, and archived specimens were histologically reclassified according to the classification of MKM-H.
Age, sex, and association with myasthenia gravis were of no prognostic importance. The R category is of significant prognostic importance, with 5- and 10-year survival rates of 93.6% and 87.3%, respectively, for R0 resections compared with 0% at 5 years for R1 and R2 resections (p < 0.001). Staging (Masaoka) proved to be a prognostic factor (5-/10-year survival: stage I, 100%/90.9%; II, 95%/88.2%; III, 55.9%/46.6%; and IV, 10.8%/ 10.8%; p < 0.001). Histologic typing according to MKM-H is also of significant prognostic importance (5/10 year survival: thymomas: medullary, 100%/100%; mixed, 100%/100%, predominantly cortical, 68.6%/68.6%; cortical, 65.8%/65.8%; thymic carcinomas: well-differentiated type, 62.3%/44.5%; thymic carcinomas other than well-differentiated type, 33.6%/26.9%; p < 0.001). Multivariate analysis demonstrated that staging (p < 0.001), R category (p < 0.026), and MKM-H classification (p < 0.028) have an independent impact on survival.
Staging (Masaoka), R category, and histologic classification (MKM-H) are important independent prognostic factors for patients with epithelial thymic tumors. Complete (R0) surgical resections should be the ultimate goal in the clinical management of patients with epithelial thymic tumors.
在一项回顾性分析中,评估了各种临床变量(年龄、性别、与重症肌无力的关联)、根据马萨oka分期、根据马里诺/基希纳/米勒 - 赫梅林克(MKM - H)分类的组织学类型以及残留肿瘤类别(R类别)的预后重要性。
对1969 - 1993年期间接受治疗的82例上皮性胸腺瘤(ETT)患者进行评估,并根据MKM - H分类对存档标本进行组织学重新分类。
年龄、性别以及与重症肌无力的关联无预后重要性。R类别具有显著的预后重要性,R0切除的5年和10年生存率分别为93.6%和87.3%,而R1和R2切除的5年生存率为0%(p < 0.001)。分期(马萨oka)被证明是一个预后因素(5/10年生存率:I期,100%/90.9%;II期,95%/88.2%;III期,55.9%/46.6%;IV期,10.8%/10.8%;p < 0.001)。根据MKM - H进行的组织学分型也具有显著的预后重要性(5/10年生存率:胸腺瘤:髓质型,100%/100%;混合型,100%/100%,主要为皮质型,68.6%/68.6%;皮质型,65.8%/65.8%;胸腺癌:高分化型,62.3%/44.5%;非高分化型胸腺癌,33.6%/26.9%;p < 0.001)。多变量分析表明,分期(p < 0.001)、R类别(p < 0.026)和MKM - H分类(p < 0.028)对生存率有独立影响。
分期(马萨oka)、R类别和组织学分类(MKM - H)是上皮性胸腺瘤患者重要的独立预后因素。完全(R0)手术切除应是上皮性胸腺瘤患者临床管理的最终目标。